Anagen effluvium (Q44014): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Eflúvio anágeno ocorre após qualquer insulto ao folículo piloso que comprometa sua atividade mitótica ou metabólica. Os pacientes apresentam queda de cabelos difusa após exposição a drogas ou produtos químicos tóxicos. Agentes quimioterápicos são mais comumente responsáveis por queda de cabelo. A queda de cabelo mais grave ocorre em associação com a doxorrubicina, as nitrosoureias e a ciclofosfamida. A queda de cabelos geralmente começa 7-14 dias após um único pulso de quimioterapia. A queda de cabelo é clinicamente mais aparente após 1-2 meses. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Anagen effluvium occurs after any insult to the hair follicle that impairs its mitotic or metabolic activity. Patients present with diffuse hair loss after an exposure to drugs or toxic chemicals. Chemotherapeutic agents are most commonly responsible for hair loss. The most severe hair loss occurs in association with doxorubicin, the nitrosoureas, and cyclophosphamide. Hair loss usually begins 7-14 days after a single pulse of chemotherapy. The hair loss is clinically most apparent after 1-2 months. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/597448549 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ED70.4 | |||||||||||||||
| Property / CURIE: CID11:ED70.4 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ED70.4 | |||||||||||||||
| Property / Canary Token: dki-india-ED70.4 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: L65.1 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 11:17, 13 August 2026
Anagen effluvium occurs after any insult to the hair follicle that impairs its mitotic or metabolic activity. Patients present with diffuse hair loss after an exposure to drugs or toxic chemicals. Chemotherapeutic agents are most commonly responsible for hair loss. The most severe hair loss occurs in association with doxorubicin, the nitrosoureas, and cyclophosphamide. Hair loss usually begins 7-14 days after a single pulse of chemotherapy. The hair loss is clinically most apparent after 1-2 months.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ED70.4 |
||
| English | Anagen effluvium |
Anagen effluvium occurs after any insult to the hair follicle that impairs its mitotic or metabolic activity. Patients present with diffuse hair loss after an exposure to drugs or toxic chemicals. Chemotherapeutic agents are most commonly responsible for hair loss. The most severe hair loss occurs in association with doxorubicin, the nitrosoureas, and cyclophosphamide. Hair loss usually begins 7-14 days after a single pulse of chemotherapy. The hair loss is clinically most apparent after 1-2 months. |
Statements
CID11:ED70.4
0 references
dki-india-ED70.4
0 references
Concluído
0 references
13 August 2026
0 references
